Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion

Eri Banno, Yosuke Togashi, Yoshihisa Kobayashi, Hidetoshi Hayashi, Tetsuya Mitsudomi, Kazuto Nishio

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion'. Together they form a unique fingerprint.

Medicine & Life Sciences